These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34115436)

  • 1. How Bayesian statistics may help answer some of the controversial questions in clinical research on Alzheimer's disease.
    Temp AGM; Lutz MW; Trepel D; Tang Y; Wagenmakers EJ; Khachaturian AS; Teipel S
    Alzheimers Dement; 2021 Jun; 17(6):917-919. PubMed ID: 34115436
    [No Abstract]   [Full Text] [Related]  

  • 2. On weighted composite scores for early Alzheimer's trials.
    Jin K; Cameron B; Dunn B
    Pharm Stat; 2019 Mar; 18(2):239-247. PubMed ID: 30565432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priorities for research consortia on Alzheimer's disease.
    Gauthier S; Garcia A; Sano M; Robert P; Senanarong V; Woodward M; Brodaty H
    Alzheimers Dement; 2010 Jul; 6(4):359-62. PubMed ID: 20630416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian statistical methods in public health and medicine.
    Etzioni RD; Kadane JB
    Annu Rev Public Health; 1995; 16():23-41. PubMed ID: 7639872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of proper conduct of clinical trials.
    Cortegiani A; Absalom AR
    Br J Anaesth; 2021 Feb; 126(2):354-356. PubMed ID: 33121749
    [No Abstract]   [Full Text] [Related]  

  • 6. Power calculations for clinical trials in Alzheimer's disease.
    Ard MC; Edland SD
    J Alzheimers Dis; 2011; 26 Suppl 3(Suppl 3):369-77. PubMed ID: 21971476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian design of noninferiority trials for medical devices using historical data.
    Chen MH; Ibrahim JG; Lam P; Yu A; Zhang Y
    Biometrics; 2011 Sep; 67(3):1163-70. PubMed ID: 21361889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis (morning panel session).
    Rockhold FW; Lindblad A; Siegel JP; Molenberghs G
    Clin Trials; 2019 Aug; 16(4):350-362. PubMed ID: 31303021
    [No Abstract]   [Full Text] [Related]  

  • 9. Disease modifying trials in Alzheimer disease: methodological and statistical issues.
    Andrieu S; Rascol O; Lang T; Grandjean H; Vellas B
    J Nutr Health Aging; 2006; 10(2):116-7. PubMed ID: 16554944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis (afternoon panel session).
    Little RJ; Tchetgen EJT; Troxel AB
    Clin Trials; 2019 Aug; 16(4):381-390. PubMed ID: 31244326
    [No Abstract]   [Full Text] [Related]  

  • 11. Retrospective Bayesian Evidence of Null Effect in Two Decades of Alzheimer's Disease Clinical Trials.
    Costa T; Manuello J; Cauda F; Liloia D
    J Alzheimers Dis; 2023; 91(2):531-535. PubMed ID: 36442201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of blindness procedures in Alzheimer's study.
    Prohovnik I
    J Nucl Med; 1994 Sep; 35(9):1566. PubMed ID: 8071713
    [No Abstract]   [Full Text] [Related]  

  • 13. Statistics in medical journals: developments in the 1980s.
    Altman DG
    Stat Med; 1991 Dec; 10(12):1897-913. PubMed ID: 1805317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimands in diabetes clinical trials.
    Min T; Bain SC
    Lancet Diabetes Endocrinol; 2020 Mar; 8(3):181-183. PubMed ID: 31972139
    [No Abstract]   [Full Text] [Related]  

  • 15. Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary.
    Rabinovici GD; Karlawish J; Knopman D; Snyder HM; Sperling R; Carrillo MC
    Alzheimers Dement; 2016 Apr; 12(4):510-5. PubMed ID: 27103054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials: is the Bayesian approach ready for prime time? Yes!
    Berry DA
    Stroke; 2005 Jul; 36(7):1621-2. PubMed ID: 15947276
    [No Abstract]   [Full Text] [Related]  

  • 17. The contribution of statistical parametric mapping in the assessment of precuneal and medial temporal lobe perfusion by 99mTc-HMPAO SPECT in mild Alzheimer's and Lewy body dementia.
    Kemp PM; Hoffmann SA; Holmes C; Bolt L; Ward T; Holmes RB; Fleming JS
    Nucl Med Commun; 2005 Dec; 26(12):1099-106. PubMed ID: 16264357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease.
    Wang G; Berry S; Xiong C; Hassenstab J; Quintana M; McDade EM; Delmar P; Vestrucci M; Sethuraman G; Bateman RJ;
    Stat Med; 2018 Sep; 37(21):3047-3055. PubMed ID: 29761523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The perils of Alzheimer's drug development.
    Schneider LS; Lahiri DK
    Curr Alzheimer Res; 2009 Feb; 6(1):77-8. PubMed ID: 19199878
    [No Abstract]   [Full Text] [Related]  

  • 20. Disease-modifying trials in Alzheimer's disease: a European task force consensus.
    Vellas B; Andrieu S; Sampaio C; Wilcock G;
    Lancet Neurol; 2007 Jan; 6(1):56-62. PubMed ID: 17166802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.